Digg StumbleUpon LinkedIn YouTube Flickr Facebook Twitter RSS Reset
Comments Off

REPRODUCTIVE BIOLOGY/ REPRODUCTIVE MEDICINE / INFERTILITY MCQs – MCQs 19

The multiple choice questions in this online test paper focuses on REPRODUCTIVE BIOLOGY/ REPRODUCTIVE MEDICINE / INFERTILITY MCQs. If you are looking for self evaluation of your PG Medical entrance exam preparation then this online REPRODUCTIVE BIOLOGY/ REPRODUCTIVE MEDICINE / INFERTILITY MCQs Test Paper will help you to evaluate your exam preparation.

Instruction for REPRODUCTIVE BIOLOGY/ REPRODUCTIVE MEDICINE / INFERTILITY MCQs:

1- This online MCQ practice test paper contains 30 questions.
2- Each question in this online practice test paper have four options and only 1 option is correct.
3- You can view the answers of this practice test paper after submitting the practice test paper.
Note: The answers mentioned at the end of practice test are the best suitable option as per our knowledge. Users shall cross-check the answers with their textbooks.

Q 1. ILDs with known etiology

 
 
 
 

Q 2. eligibility for α1 antitrypsin augmentation therapy requires a serum α1 antitrypsin level of

 
 
 
 

Q 3. BODE score as a predictor of COPD mortality includes all except

 
 
 
 

Q 4. LVRS (lung volume reduction surgery) is not recommended if pulmonary artery systolic pressure is

 
 
 
 

Q 5. vaccine recommended before administering α1 antitrypsin augmentation therapy

 
 
 
 

Q 6. ILDs include

 
 
 
 

Q 7. initial features most frequent in ILD patients

 
 
 
 

Q 8. bacteria frequently implicated in COPD exacerbations include all except

 
 
 
 

Q 9. which season is appropriate for giving influenza vaccination yearly in patients of COPD

 
 
 
 

Q 10. initial insult leading to inflammation and fibrosis in ILD is to

 
 
 
 

Q 11. which is used in Augmentation therapy of COPD

 
 
 
 

Q 12. ILD with symptoms and signs from a chronic presentation include all except

 
 
 
 

Q 13. long acting β2 adrenergic receptor agonist include

 
 
 
 

Q 14. granulomas in granulomatous lung disease consists of

 
 
 
 

Q 15. which therapy is demonstrated to decrease mortality in COPD patients

 
 
 
 

Q 16. N-acetyl cysteine action

 
 
 
 

Q 17. risk factors predicting increased hospital admission for acute exacerbation in COPD include all except

 
 
 
 

Q 18. ILDs involves which of the following in lung parenchyma

 
 
 
 

Q 19. patient with which of the following are most likely to benefit from LVRS (lung volume reduction surgery)

 
 
 
 

Q 20. myofibroblasts produce

 
 
 
 

Q 21. effective respiratory stimulant

 
 
 
 

Q 22. drugs not included in contraindicated list in GOLD guidelines

 
 
 
 

Q 23. risk factors predicting increased hospital admission for acute exacerbation in COPD include all except

 
 
 
 

Q 24. LVRS (lung volume reduction surgery) is used in the management of

 
 
 
 

Q 25. patients with idiopathic pulmonary typically have all of the following features except

 
 
 
 

Q 26. patient with which of the following are not candidates for LVRS (lung volume reduction surgery)

 
 
 
 

Q 27. Lung regeneration agent includes

 
 
 
 

Q 28. Lung response is alveolitis, interstitial inflammation and fibrosis in all of the following ILDs except

 
 
 
 

Q 29. theophylline besides bronchodilator effect also has which therapeutic effect

 
 
 
 

Q 30. ILD with acute presentation include all except

 
 
 
 


Comments are closed.